glutathione ros scavenger Frontiers Reactive oxygen species (ROS) scavenging

Therapeutic Targets: Strategies such as mitochondrial-targeted antioxidants (e.g., MitoQ) and mitophagy activators (e.g., Urolithin A) show promise in preclinical studies

Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration

Mechanistically, there is a negative correlation between KLF2 and GPX4, and KLF2 deficiency increases the level of GPX4 and inhibits ferroptosis, promoting the invasion and migration of renal cancer cells, which can be reversed by overexpression of GPX4, 150 indicating that promoting ferroptosis of cancer cells may be a promising strategy for the clinical treatment of advanced RCC

For Medispa and Aesthetic Professionals Medical spas and aesthetic practices increasingly offer peptide therapies as part of comprehensive wellness programs